Maria Morales-Suarez-Varela | Medicine and Pharmacy | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Maria Morales-Suarez-Varela | Medicine and Pharmacy | Best Researcher Award
Full professor | University of Valencia | Spain

Prof. Dr. Maria Morales-Suárez-Varela is a distinguished academic and researcher specializing in public health, preventive medicine, nutrition, and environmental epidemiology. Serving as a Full Professor at the Universitat de València, she has made outstanding contributions to advancing scientific understanding of the relationships between environmental exposures, nutrition, and population health. She holds a Doctorate and a Licentiate in Medicine and Surgery, with advanced expertise in preventive and public health sciences. As Principal Investigator of prominent research groups within the CIBER of Epidemiology and Public Health and the Universitat de València, she has led numerous national and international projects funded by competitive public and private agencies. Her scholarly impact is reflected in hundreds of high-quality publications indexed in leading databases, an extensive record of citations, and a strong h-index that underscores her scientific influence. She has supervised numerous doctoral theses and has presented extensively at global conferences. Her research integrates epidemiological evidence with policy-relevant health solutions, with special focus on maternal and child health, dietary patterns, environmental risks, and population well-being. Recognized for her leadership and excellence, she has received multiple distinctions for research merit and contributes actively to scientific networks, editorial boards, and peer-review committees. Prof. Morales-Suárez-Varela exemplifies academic rigor, innovation, and dedication to public health advancement, making her a highly deserving candidate for this award.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Morales-Suárez-Varela, M., et al. (2025). Effect of the Mediterranean diet on BMI and body composition: A preliminary pre-post intervention study in pediatric overweight patients. Nutrition.

2. Morales-Suárez-Varela, M., et al. (2025). Long-term prognostic implications of type 2 diabetes mellitus in colorectal cancer patients. Colorectal Disease.

3. Morales-Suárez-Varela, M., et al. (2025). Systematic review of prenatal exposure to PM2.5 and its chemical components and their effects on neurodevelopmental outcomes in neonates.

4. Morales-Suárez-Varela, M., et al. (2025). Helminth/Protozoan coinfections in chronic fascioliasis cases in human hyperendemic areas: High risk of multiparasitism linked to transmission aspects and immunological, environmental and social factors. Tropical Medicine and Infectious Disease.

5. Morales-Suárez-Varela, M., et al. (2025). Analysis of demographic and health characteristics and adherence to the Mediterranean diet in pregnant women: MEDAS questionnaire. Semergen.

Prof. Dr. Maria Morales-Suárez-Varela’s research advances global understanding of how environmental, nutritional, and lifestyle factors influence public health outcomes. Her work bridges science and policy, driving innovations that promote healthier populations, sustainable healthcare practices, and evidence-based prevention strategies worldwide.

Gillian Mahumane | Pharmaceutical science | Best Researcher Award

Published on by World Top Scientists

Dr. Gillian Mahumane | Pharmaceutical science | Best Researcher Award

Lecturer at University of the Witwatersrand, South Africa

Dr. Gillian D. Mahumane is a pharmaceutical scientist and lecturer whose research advances neural-targeted and vaginal drug delivery systems with a strong focus on translational pharmaceutics and global health impact. Her work spans innovative platforms such as antimicrobial cryogels, polymeric films, and nanofiber scaffolds for applications in neural repair and women’s health. She has published extensively in peer-reviewed journals, contributed to book chapters, and presented at international conferences, establishing her as a thought leader in advanced drug delivery. Beyond research, she is deeply committed to mentorship, supervising postgraduate students, co-founding research support initiatives, and shaping biopharmaceutics curricula to bridge science and practice. Recognition through prestigious fellowships and membership in the Global Young Academy highlights her growing leadership in science communication, innovation management, and policy engagement. Combining scientific excellence, mentorship, and advocacy, Dr. Mahumane exemplifies a new generation of researchers dedicated to advancing biomedical innovation and societal health impact.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Dr. Gillian D. Mahumane has built a solid academic foundation in pharmaceutical sciences through progressive qualifications at the University of the Witwatersrand. She completed her Bachelor of Pharmacy, where her early research explored drug delivery using polycaprolactone-based systems. Building on this, she earned her Master of Pharmacy with distinction, focusing on the antimicrobial activity and chemical analysis of Eucalyptus radiata essential oil, which deepened her expertise in natural products and pharmaceutical analysis. Her doctoral studies marked a significant step into advanced biomaterials and regenerative medicine, culminating in a PhD in which she designed and evaluated nano-reinforced hydro-filled 3D scaffolds for neural tissue engineering. This multidisciplinary training equipped her with expertise in pharmaceutics, biomaterials, and pharmacokinetics, forming the basis for her later research into neural-targeted and vaginal drug delivery platforms. Her academic journey reflects both depth in specialized research and breadth across pharmaceutical sciences, positioning her for leadership in translational pharmaceutics.

Experience

Dr. Gillian Mahumane is a lecturer in biopharmaceutics and a researcher with the Wits Advanced Drug Delivery Platform, where she combines teaching, mentorship, and cutting-edge research. Her role encompasses supervising postgraduate projects, integrating research into curriculum design, and driving institutional research support strategies. She has gained valuable international experience through fellowships with the Population Council’s Centre for Biomedical Research in New York, focusing on vaginal drug delivery innovation, and the UCL-Wits Public Voices Fellowship, which enhances her leadership in science communication. In addition to her academic contributions, she has engaged in policy-linked research initiatives and co-founded a research support group that mentors over thirty postgraduate students. Her professional journey is defined by a balance of laboratory innovation, translational research, and capacity building. Through these roles, she has cultivated expertise not only as a scientist but also as an educator, mentor, and emerging leader in pharmaceutical innovation and global health.

Research Focus

Dr. Gillian Mahumane’s research is anchored in translational pharmaceutics, particularly neural-targeted and vaginal drug delivery systems designed to address unmet clinical needs. She has explored advanced biomaterials, including nanofiber scaffolds, polymeric films, and antimicrobial cryogels, with applications ranging from brain tissue regeneration to intravaginal microbicide delivery. Her doctoral research pioneered nano-reinforced hydro-filled 3D scaffolds for neural repair, addressing challenges in tissue engineering and regenerative medicine. More recently, she has advanced vaginal platforms for multipurpose prevention technologies, integrating biopharmaceutics and global health perspectives. Complementing these laboratory innovations, she contributes to pharmacokinetics research, designing teaching models and patient-centered dosage regimens. Her focus extends beyond discovery to translation, aiming to move research outputs into real-world applications that improve health outcomes. By integrating pharmaceutical sciences, biomaterials engineering, and policy engagement, her research not only contributes to academic knowledge but also supports broader societal impact in women’s health and neurotherapeutics.

Award and Honor

Dr. Gillian Mahumane has been recognized with multiple awards and fellowships that underscore both her scientific excellence and her emerging leadership in global health research. She is a member of the Global Young Academy, an honor that acknowledges her as a voice for African biomedical innovation and positions her within an influential international network of scientists. Her selection as a CBR/Jeiven Fellow at the Population Council in New York highlighted her contributions to vaginal drug delivery innovation, while her UCL-Wits Public Voices Fellowship reflects her strength in science communication and policy engagement. She has also been featured in initiatives promoting women in science, innovation in pharmaceutical education, and capacity building in Africa. Beyond formal fellowships, her research and teaching have been showcased through institutional awards, invited talks, and international conference presentations. These recognitions emphasize not only her scholarly achievements but also her commitment to mentorship, innovation, and societal health impact.

Publication Top Notes

Title: 3D scaffolds for brain tissue regeneration: architectural challenges
Authors: GD Mahumane, P Kumar, LC du Toit, YE Choonara, V Pillay
Year: 2018
Citations: 90

Title: Repositioning N-Acetylcysteine (NAC): NAC-Loaded Electrospun Drug Delivery Scaffolding for Potential Neural Tissue Engineering Application
Authors: GD Mahumane, P Kumar, V Pillay, YE Choonara
Year: 2020
Citations: 29

Title: Chemical composition and antimicrobial activity of Eucalyptus radiata leaf essential oil, sampled over a year
Authors: GD Mahumane, SF van Vuuren, G Kamatou, M Sandasi, AM Viljoen
Year: 2016
Citations: 13

Title: Impact of illegible prescriptions on dispensing practice: a Pilot Study of South African Pharmacy Personnel
Authors: T Modi, N Khumalo, R Shaikh, Z Booth, S Leigh-de Rapper, GD Mahumane
Year: 2022
Citations: 9

Title: Antimicrobial activity and chemical analysis of Eucalyptus radiata leaf essential oil
Author: GD Mahumane
Year: 2016
Citations: 5

Title: A review of bigels for neurotrauma therapeutics: Structural insights for tissue microenvironment alignment
Authors: YC Botle Moswatsi, GD Mahumane, Pradeep Kumar
Year: 2025
Citations: 1

Title: The potential for Eucalyptus radiata leaf essential oil use as a commercial antimicrobial
Authors: GD Mahumane, SF van Vuuren, AM Viljoen, G Kamatou
Year: 2015
Citations: 1

Title: A Dual-Template Molecularly Imprinted Polymer to Inhibit Quorum Sensing Molecules: Theoretical Design, Optimized Synthesis, Physicochemical Characterization and Preliminary Analysis
Authors: PL Khonzisizwe Somandi, TS Mwale, M Sobiech, D Klejn, GD Mahumane, YE Choonara, J Giebułtowicz, P Luliński
Year: 2025

Title: Bio-inspired nanofibres: Weaving biological tissue with nanomedicine to repair brains
Authors: GD Mahumane, YE Choonara
Year: 2022

Title: Nano-enabled systems for neural tissue regenerative applications
Authors: GD Mahumane, P Kumar, YE Choonara
Year: 2022

Title: Nano-reinforced hydro-filled 3D scaffold for neural tissue engineering (PhD Thesis)
Author: GD Mahumane
Year: 2021

Conclusion

Dr. Gillian D. Mahumane has established a strong and growing research portfolio in pharmaceutical sciences, with particular strengths in neural tissue engineering, vaginal drug delivery platforms, and biomaterials innovation. Her most-cited works, such as those on 3D scaffolds for brain tissue regeneration and electrospun drug delivery systems, highlight her contributions to advancing regenerative medicine and translational pharmaceutics. In addition, her studies on natural products and antimicrobial applications demonstrate her versatility across pharmaceutical research domains. While some of her most recent publications are still in the early stages of gaining citations, they reflect cutting-edge directions in drug delivery and biomedical innovation. Taken together, her body of work illustrates both academic impact and practical relevance, positioning her as a promising and influential researcher. With continued advancement of her translational outputs and expanded global collaborations, Dr. Mahumane is well-placed to make sustained contributions worthy of recognition through research excellence awards.

Nai-Dong Chen | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Prof. Nai-Dong Chen | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

department leader at West Anhui University, China

Professor Chen, born in September 1972 in Jinzhai County, Anhui Province, is a distinguished scholar and a leading figure in the field of traditional Chinese medicine and natural product research. Currently, he serves as a Distinguished Professor (Dabieshan Scholar) at West Anhui University, where he also holds multiple leadership roles, including Deputy Director of the Experimental Teaching and Training Management Department, and Director of the Postdoctoral Research Workstation. He is a doctoral supervisor affiliated with Anhui University of Chinese Medicine and Anhui Agricultural University, and leads the Anhui Provincial Key Laboratory of Traditional Chinese Medicine Quality Evaluation and Enhancement. Prof. Chen is also the head of several strategic research teams and innovation platforms that focus on the modernization and industrialization of herbal medicine. A nationally recognized talent under the Anhui Provincial Special Support Plan, he has been honored as a Top Talent of Lu’an City, Outstanding Teaching Faculty of West Anhui University, and nominee for Lu’an Distinguished Talent Award. His scholarly influence is reinforced by his role as a reviewer for the National Natural Science Foundation and active participation in national academic societies, contributing to both academic and practical advancements in pharmaceutical science.

Professional Profile

Education

Professor Chen holds a PhD in Pharmaceutical Sciences, which provided the foundation for his career-long dedication to the research and development of traditional Chinese medicine. With a strong academic background rooted in pharmacy, chemistry, and biotechnology, his educational journey integrated classical medicinal knowledge with modern scientific methodology. Over the years, he has further enhanced his qualifications through postdoctoral research and continuous academic training, establishing himself as a multidisciplinary expert. His early education fostered a strong commitment to scientific excellence and innovation, particularly in areas such as medicinal chemistry, pharmacology, and natural product extraction. His academic milestones have been complemented by hands-on experience in laboratory work, clinical trials, and academic leadership. Prof. Chen’s teaching and mentorship roles at institutions such as Anhui University of Chinese Medicine and Anhui Agricultural University reflect a solid academic lineage and dedication to nurturing the next generation of researchers. His consistent academic growth, paired with strategic collaboration with scientific institutions, has enabled him to contribute meaningfully to the evolving landscape of pharmaceutical education in China. His educational achievements form the intellectual backbone of his extensive work in TCM standardization, drug development, and plant-based biomedicine.

Professional Experience

Throughout his career, Professor Chen has accumulated a wealth of professional experience spanning academia, research administration, and national-level scientific leadership. As a Professor at West Anhui University, he has played a pivotal role in curriculum development, talent cultivation, and institutional research strategy. He concurrently serves as Vice Secretary of the Party Committee and Deputy Director of the Experimental Training Management Department, while also leading the Postdoctoral Workstation and provincial laboratories in quality enhancement of traditional Chinese medicine. Prof. Chen is the Chief Investigator and Team Leader of several key innovation teams focused on medicinal plant research and pharmacological innovation. Beyond his university, he is deeply involved in provincial and national science policymaking, contributing as a Communications Reviewer for NSFC, and as a standing member of the Chinese Under-Forest Economy Society and Anhui Botanical Society. Over the years, he has led or participated in over 20 major scientific research projects, with total funding in the multimillion-yuan range. His work often bridges the gap between academia and industry, evidenced by extensive industry-academic collaboration, numerous patents, and standard-setting activities. His experience reflects a mature balance of teaching, research, and service that defines his leadership in Chinese pharmaceutical sciences.

Research Interests

Professor Chen research interests center on the quality evaluation, efficacy enhancement, and innovation of traditional Chinese medicines (TCMs). A key focus of his work is the phytochemistry, pharmacokinetics, and bioactivity of medicinal herbs, particularly Dendrobium huoshanense, a rare and valuable plant species. His investigations delve into metabolomics, network pharmacology, and structure-activity relationships, aiming to improve standardization and therapeutic potential of herbal products. He has also led efforts to decode the geographical specificity (daodi) and biological transformation mechanisms of active components in medicinal plants. His interest in synergistic fermentation, antioxidant activity, and enzyme inhibition studies has resulted in innovative methods for improving bioavailability and therapeutic outcomes of plant-based compounds. Additionally, Professor Chen integrates modern analytical technologies such as UPLC-MS/MS, NIR spectroscopy, and bioinformatics into his research toolkit, enhancing the precision and scalability of TCM research. His collaborative work with pharmaceutical companies aims to commercialize novel herbal formulations and functional health products. As TCM gains global interest, Prof. Chen’s research aligns with the trend of merging traditional knowledge with cutting-edge biomedical science, addressing critical issues in herbal medicine safety, efficacy, and modernization.

Awards and Honors

Professor Chen has been recognized with numerous prestigious awards and honors, reflecting his profound impact on pharmaceutical research and education. Among his most notable achievements are two Second Prizes for Science and Technology Progress in Anhui Province and the Special Award for Technological Advancement by the China General Chamber of Commerce. These accolades signify his contributions to both fundamental science and its practical application in the modernization of traditional Chinese medicine. He was also honored with the Anhui Provincial Teaching Achievement Award (Second Prize), highlighting his role in academic innovation and pedagogy. As a recipient of the Anhui Provincial Leading Talent under the Special Support Plan, Prof. Chen is acknowledged as a strategic scientific leader. He has been awarded Top Talent and Outstanding Scholar titles in Lu’an City, and recognized as a Teaching Master at West Anhui University. His selection as Principal Investigator for National Natural Science Foundation of China (NSFC) projects further underscores his status in China’s scientific community. With over 40 patent applications, 23 industry and local standards developed, and extensive mentorship roles, his accolades are both deep and diverse. These honors confirm his legacy as a highly influential and respected figure in biomedical and TCM research.

Conclusion

Professor 陈乃东 is a highly suitable candidate for the Best Researcher Award. His outstanding achievements in TCM quality research, natural products pharmacology, and regional development through science and innovation reflect the hallmarks of a leading researcher. His contributions are scientifically rigorous, socially relevant, and academically influential. With minor enhancements in global engagement and innovation translation, his profile could further stand out on the world stage.

Publications Top Notes

  • Author(s): Hao, Jingwen; Wang, Weiting; Chen, Naidong; Shen, Yan
    Year: 2025
    Title: Identification of 13 natural antioxidants in green calyx plum using AAPH, ABTS, and FRAP-coupled HPLC-DAD via QTOF-MS/MS
    Journal: Food Chemistry
    Citations: 0

  • Author(s): Chen, Naidong
    Year: 2025
    Title: Mechanism for the Inhibition of α-Glucosidase by Peptide Tyr-Pro-Ile-Trp (YPIW) and Its Stability
    Journal: Shipin Kexue / Food Science
    Citations: 0

  • Author(s): Zheng, Shaojun; Li, Sheng; Diao, Xiaohan; Chen, Naidong
    Year: 2025
    Title: Prunus mume Alleviates Hyperuricemic Renal Injury: Insights From Network Pharmacology and Experimental Models
    Journal: Biomedical Chromatography
    Citations: 0

  • Author(s): Hao, Kuku; Wang, Qijin; Wei, Shengxiang; Zheng, Shaojun; Zhang, Manman; Chen, Naidong (co-author)
    Year: 2025
    Title: Structural characterization and anti-inflammatory activity of a neutral polysaccharide from Dendrobium huoshanense C. Z. Tang et S. J. Cheng
    Journal: International Journal of Biological Macromolecules
    Citations: 0

  • Author(s): Hao, Jingwen; Fan, Xuanxuan; Chen, Naidong; Xiao, Jun; Zhang, Manman
    Year: 2025
    Title: A novel method for the simultaneous determination of flavonoids in Pteridium aquilinum via SPE combined with UPLC-DAD via QAMS
    Journal: Journal of Food Composition and Analysis
    Citations: 0

 

Mrs. fangyan He | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Mrs. fangyan He | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Senior Experimentalist at Yunnan University of Traditional Chinese Medicine, China

He Fangyan is a distinguished researcher specializing in the pharmacodynamics and pharmacokinetics of traditional Chinese medicine. Currently serving as a Senior Experimentalist at Yunnan University of Traditional Chinese Medicine, she has led multiple high-impact studies focusing on ischemic stroke mechanisms and brain pharmacokinetics. With a commitment to advancing neuropharmacology, she has secured prestigious research grants, contributed to key scientific advancements, and developed innovative methodologies in cerebral ischemia treatment. Her expertise extends to drug metabolism, blood-brain barrier protection, and targeted drug delivery, making her a prominent figure in the field. Through her patents, publications, and ongoing research, she continues to bridge the gap between traditional Chinese medicine and modern pharmacological science.

Professional Profile

Education

He Fangyan holds an advanced degree in pharmacology and traditional Chinese medicine research, equipping her with interdisciplinary expertise in both experimental and clinical pharmacokinetics. She has undergone rigorous training in drug absorption, metabolism, and pharmacodynamics, particularly focusing on ischemic stroke therapies. Her academic background includes specialized studies in cerebral ischemia-reperfusion injury and neuroprotection, which laid the foundation for her innovative research contributions. She has further enhanced her knowledge through postgraduate research projects, technical training in pharmacological analysis, and collaborations with leading scientists in neurological drug development. Her education has provided her with a strong analytical and methodological foundation, enabling her to conduct cutting-edge research in traditional Chinese medicine’s role in stroke management.

Professional Experience

With extensive experience in experimental pharmacology and neuroscience, He Fangyan has held a senior research position at Yunnan University of Traditional Chinese Medicine, leading multiple research projects funded by national and provincial grants. She has played a pivotal role in advancing traditional Chinese medicine applications for stroke treatment, particularly through the study of Gastrodia’s neuroprotective effects. Over the years, she has worked on high-impact studies integrating brain microdialysis, PK/PD modeling, and oxidative stress mechanisms. In addition to academic research, she has contributed to methodology development in neuropharmacology, ensuring precise drug targeting and evaluation of traditional medicine compounds. Her professional contributions also extend to mentoring young researchers and fostering interdisciplinary collaborations, strengthening the field of pharmacokinetics and neuroprotection.

Research Interests

He Fangyan’s primary research interests revolve around cerebral ischemia, blood-brain barrier protection, and pharmacokinetics of traditional Chinese medicine compounds. She is particularly focused on understanding the mechanisms of ischemic stroke and the therapeutic potential of Gastrodia-derived compounds in treating oxidative stress-induced brain damage. Her studies employ microdialysis techniques, drug metabolism analysis, and neuroprotective compound development, making significant contributions to stroke research. She is also deeply invested in the translation of traditional Chinese medicine principles into modern pharmacological applications, aiming to bridge ancient remedies with contemporary scientific methodologies. Additionally, she explores novel drug delivery systems and prodrug mechanisms, ensuring targeted treatment with minimal side effects for cerebrovascular diseases.

Awards and Honors

He Fangyan has been recognized for her outstanding contributions to traditional Chinese medicine research and neuropharmacology. She has received funding from prestigious institutions such as the National Natural Science Foundation of China and the Yunnan Science and Technology Department, reflecting the significance of her work. Her patented innovations in cerebral ischemia treatment have earned acclaim, contributing to advancements in stroke therapy. She has also published extensively in SCI-indexed journals, further solidifying her academic reputation. As a key figure in pharmacokinetics and stroke research, she has been invited to speak at academic conferences and collaborate on national research initiatives. Her dedication to scientific progress and innovation continues to garner recognition, positioning her as a leading researcher in the field of traditional Chinese medicine and neuroscience.

Conclusion

He Fangyan is a strong candidate for the Best Researcher Award due to extensive contributions to pharmacokinetics and stroke research, significant grant funding, patents, and high-impact journal publications. Strengthening industry ties, international collaborations, and academic outreach could further solidify eligibility for top-tier research awards.

Publications Top Noted

  • He, F., Feng, J., Sun, H., Xu, Y., Yan, H., Song, X., Wang, Y., Li, X., & Lin, Q. (2024). Protective Effect of Protocatechuic Aldehyde on Cerebral Ischemia/Reperfusion Injury in Rats through Blood–Brain Barrier Protection. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1007/s10517-024-06264-z

  • He, F., Xu, C., Feng, J., Sun, H., Yan, M., Yang, Q., Zhou, X., Yang, J., & Lin, Q. (2024). Pharmacokinetics of 4-Hydroxybenzaldehyde in Normal and Cerebral Ischemia–Reperfusion Injury Rats Based on Microdialysis Technique. European Journal of Drug Metabolism and Pharmacokinetics. https://doi.org/10.1007/s13318-023-00863-3

  • He, F., Ma, C., Feng, J., Li, X., Xia, S., Lin, Q., Dai, R., & He, F. (2021). Angiogenesis effects of 4-methoxy benzyl alcohol on cerebral ischemia-reperfusion injury via regulation of VEGF-Ang/Tie2 balance. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2021-0118

  • He, F., Dai, R., Zhou, X., Li, X., Song, X., Yan, H., Meng, Q., Yang, C., & Lin, Q. (2019). Protective effect of 4-Methoxy benzyl alcohol on the neurovascular unit after cerebral ischemia reperfusion injury. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2019.109260

  • He, F., Duan, X., Dai, R., Li, Y., & Lin, Q. (2017). Protective Effect of 4-Methoxy Benzyl Alcohol on the Blood–Brain Barrier after Cerebral Ischemia Reperfusion Injury. Journal of Stroke and Cerebrovascular Diseases. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.01.018

 

Nceba Gqaleni | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Prof. Nceba Gqaleni | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Research Professor at University of KwaZulu-Natal, South Africa

Professor Nceba Gqaleni is a renowned academic and researcher at the University of KwaZulu-Natal, South Africa. He currently serves as an Acting Academic Leader in the Discipline of Traditional Medicine and as a Research Professor. With a passion for integrating traditional medicine into mainstream healthcare, his research aims to address health challenges facing Africa, including HIV, diabetes, and cancer. His work on herbal treatments and immunomodulators has positioned him as a pioneer in exploring alternative therapies. Prof. Gqaleni’s research is characterized by the synergy between modern science and indigenous knowledge systems, contributing significantly to the global healthcare landscape. His work continues to impact public health, with ongoing clinical trials and innovative studies aimed at improving health outcomes. Additionally, he is committed to training the next generation of researchers, having mentored numerous postdoctoral, PhD, and master’s students.

Professional Profile

Education

Professor Nceba Gqaleni’s educational background is rooted in biochemistry, with a PhD in Biochemistry from the University of Strathclyde in Glasgow, UK. He also holds a Master’s degree in Biochemistry from the University of KwaZulu-Natal (UKZN), South Africa. His academic journey has been marked by a deep interest in both the molecular and traditional aspects of medicine, leading him to pursue research that bridges these fields. His formal education laid the foundation for a distinguished career in both academia and research, where he has applied his scientific expertise to explore alternative therapies and the integration of traditional medicine into contemporary health systems. Prof. Gqaleni’s educational path reflects a commitment to advancing knowledge and improving healthcare, particularly in the African context.

Professional Experience

Professor Gqaleni’s professional experience spans academia, research, and leadership. He currently holds the position of Acting Academic Leader in the Discipline of Traditional Medicine at the University of KwaZulu-Natal. His role involves guiding academic initiatives and research in traditional medicine, while also providing leadership in curriculum development and research supervision. In addition to his academic responsibilities, Prof. Gqaleni has led numerous significant research projects, particularly focused on traditional medicine’s role in addressing major health issues such as HIV and diabetes. His extensive work in supervising postgraduate students, including over 7 postdoctoral researchers, 12 PhD candidates, and 25 master’s students, demonstrates his dedication to nurturing the next generation of scholars and researchers. Prof. Gqaleni’s professional experience is a blend of academic excellence, mentorship, and groundbreaking research in the field of traditional medicine and biochemistry.

Research Interests

Professor Nceba Gqaleni’s research interests lie at the intersection of biochemistry and traditional medicine, with a primary focus on finding alternative treatments for diseases prevalent in Africa, such as HIV, diabetes, and cancer. He has led pioneering research on herbal compositions for the treatment of HIV and is currently conducting clinical trials for a patented HIV cure. In addition to HIV, his research extends to cancer therapies, immunomodulators, and the application of Indigenous phytotherapy in managing diseases like diabetes and HIV. Prof. Gqaleni’s ongoing research projects also explore the health and wellness of Indigenous peoples, particularly in the context of climate change and global health disparities. His work is driven by the goal of bridging the gap between traditional healing practices and modern medical approaches, thereby improving health outcomes in African communities and globally.

Awards and Honors

Professor Nceba Gqaleni’s career has been marked by significant achievements and recognition. He has been honored for his pioneering work in traditional medicine and biochemistry, particularly in the field of HIV and diabetes treatment. One of his notable accomplishments is the filing of a patent for a herbal composition aimed at curing HIV, which is currently undergoing clinical trials. Prof. Gqaleni has also received substantial funding for his research, including a $4.4 million NIH grant for a study on Indigenous phytotherapy. His contributions to science and public health have earned him the respect of both academic and medical communities. Prof. Gqaleni’s work in advancing the integration of traditional medicine into global health systems continues to garner international attention and recognition. His awards and honors reflect his exceptional leadership and groundbreaking contributions to healthcare research.

Conclusion

Professor Nceba Gqaleni demonstrates exceptional potential for the Best Researcher Award due to his innovative contributions to HIV treatment, integration of traditional medicine, and impactful mentorship. His work addresses critical health challenges in Africa, blending traditional knowledge with modern scientific methods. While broader dissemination and commercialization efforts could strengthen his profile, his contributions make him a strong contender for the award.

Publications Top Noted

  • Indigenous Medicinal Plants Used in the Management of Diabetes in Africa: 5 Years (2019–2024) in Perspective
    • Authors: Frimpong, E.K., Thembane, N., Hlatshwayo, S., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 2
  • Review on the Anti-Hyperglycemic Potential of Psidium guajava and Seriphium plumosum L.
    • Authors: Thembane, N., Hlatshwayo, S., Ngcobo, M., Ngubane, P., Gqaleni, N.
    • Year: 2024
    • Citations: 1
  • Erratum: An in vitro study to elucidate the effects of Product Nkabinde on immune response in peripheral blood mononuclear cells of healthy donors
    • Authors: Setlhare, B., Letsoalo, M., Nkabinde, S.A., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 0
  • An in vitro study to elucidate the effects of product Nkabinde on immune response in peripheral blood mononuclear cells of healthy donors
    • Authors: Setlhare, B., Letsoalo, M., Nkabinde, S.A., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 1
  • Analysis of Three Species of Cassipourea Traditionally Used for Hypermelanosis in Selected Provinces in South Africa
    • Authors: Mpofana, N., Yalo, M., Gqaleni, N., Dlova, N.C., Hussein, A.A.
    • Year: 2024
    • Citations: 0
  • Melasma in People with Darker Skin Types: A Scoping Review Protocol on Prevalence, Treatment Options for Melasma, and Impact on Quality of Life
    • Authors: Mpofana, N., Chibi, B., Gqaleni, N., Kgarosi, K., Dlova, N.C.
    • Year: 2023
    • Citations: 3
  • The Effect of Melasma on the Quality of Life in People with Darker Skin Types Living in Durban, South Africa
    • Authors: Mpofana, N., Paulse, M., Gqaleni, N., Hussein, A., Dlova, N.C.
    • Year: 2023
    • Citations: 0
  • The Met and Unmet Health Needs for HIV, Hypertension, and Diabetes in Rural KwaZulu-Natal, South Africa: Analysis of a Cross-Sectional Multimorbidity Survey
    • Authors: Singh, U., Olivier, S., Cuadros, D., Ramnanan, A., Harilall, S., Gqaleni, N.
    • Year: 2023
    • Citations: 5
  • An Investigation into the Acute and Subacute Toxicity of Extracts of Cassipourea flanaganii Stem Bark In Vivo
    • Authors: Mpofana, N., Chipangura, J.K., Paulse, M., Hussein, A.A., Crouch, N.R.
    • Year: 2023
    • Citations: 2
  • Treatment of Melasma on Darker Skin Types: A Scoping Review
    • Authors: Mpofana, N., Chibi, B., Visser, T., Hussein, A.A., Dlova, N.C.
    • Year: 2023
    • Citations: 4

 

Anthony Mullin | Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Mr. Anthony Mullin | Pharmaceutical Science | Best Researcher Award

PhD Research Molecular Biology, University of Hertfordshire, United Kingdom

Anthony James Mullin is a dedicated researcher with a profound passion for advancing knowledge in tissue culture management and forensic analytical chemistry. His strong academic background and extensive experience in both research and commercial settings make him a vital contributor to the fields of cancer research and psychoactive substance analysis.

Profile

Orcid

Strengths for the Award

Anthony Mullin demonstrates a solid foundation of research expertise, particularly in areas such as psychopharmacology, drug misuse, and analytical chemistry. His work, especially in forensic analysis and the study of New Psychoactive Substances (NPS), reflects innovative approaches, such as applying AI for historical drug misuse trend analysis. His collaboration with renowned researchers like Professor Schifano and Dr. Guirguis further highlights his contributions. Mullin’s research has been recognized at international conferences, underscoring its impact and relevance. His Oxford Press Award for Outstanding Achievements in Bioscience adds to his credibility. Mullin’s well-rounded skill set, including tissue culture management and advanced drug stability analysis, combined with his technical proficiency (e.g., UHPLC, GCMS) and multidisciplinary publications, strengthens his candidacy for the award.

Areas for Improvement

While Mullin’s research portfolio is impressive, his Research Influence (RI) score of 7.0 could benefit from more citations to increase visibility and impact within the academic community. His work, although influential in niche areas, might gain broader recognition by focusing on publishing in higher-impact journals and increasing collaboration beyond his current research groups. Additionally, more outreach and involvement in global networks could amplify his contributions. Although he has presented at international conferences, consistent engagement with the wider research community through more frequent publications and presentations could enhance his profile.

Education 🎓

Anthony graduated with a 1st Class BSc (Hons) in Chemical Biology from the University of Hertfordshire in 2012. His remarkable academic performance earned him the prestigious Oxford Press Award for Outstanding Achievements in Bioscience, underscoring his commitment to excellence in the field of biosciences.

Experience 💼

Anthony has served as a Freelance Research Assistant and Author at the University of Hertfordshire and Swansea University, where he worked within the Psychopharmacology, Drug Misuse, and NPS research group. His previous roles include Research Assistant and Laboratory Technician at the University of Hertfordshire, as well as positions in scientific recruitment and quality control analysis. His diverse experience has equipped him with a unique skill set that bridges the gap between scientific research and practical application.

Research Interests 🔬

Anthony’s research interests are centered around tissue culture management, bio-assay development, and the forensic analysis of new psychoactive substances (NPS). He is particularly interested in utilizing artificial intelligence to enhance analytical methodologies and improve drug stability testing processes.

Awards 🏆

Anthony has received several accolades, including the Oxford Press Award for Outstanding Achievements in Bioscience for his exceptional academic performance. His contributions to research have also led to presentations at prestigious conferences, further establishing him as a respected figure in his field.

Publications Top Notes 📝

  1. Mullin, A., Scott, M., Vaccaro, G., Floresta, G., Arillotta, D., Catalani, V., Corkery, J.M., Stair, J.L., Schifano, F., Guirguis, A. (2024). Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques. Pharmacy 12, 13.
    • Citations: 0
  2. Mullin, A., Scott, M., Vaccaro, G., Gittins, R., Ferla, S., Schifano, F., Guirguis, A. (2023). Handheld Raman Spectroscopy in the First UK Home Office Licensed Pharmacist-Led Community Drug Checking Service. Int. J. Environ. Res. Public Health 20, 4793.
    • Citations: 3
  3. Williams D T, Straw N, Townsend M, Wilkinson A S, and Mullin, A. (2013). Monitoring oak processionary moth Thaumetopoea processionea L. using pheromone traps: the influence of pheromone lure source, trap design and height above the ground on capture rates. Agricultural and Forest Entomology 15, pp.126–134.
    • Citations: 20

Conclusion

Anthony Mullin is a promising researcher with significant achievements in psychopharmacology, drug misuse, and analytical chemistry. His technical skills, innovative approaches, and notable academic accomplishments make him a strong candidate for the “Best Researcher Award.” With targeted efforts to increase the visibility and impact of his work, particularly through citations and global collaboration, Mullin could further solidify his standing in the research community

Baby Rabiya Parveen | Pharmaceutical Chemistry | Best Researcher Award

Published on by World Top Scientists

Ms. Baby Rabiya Parveen | Pharmaceutical Chemistry | Best Researcher Award

Associate Professor, S.D. College of Pharmacy & Vocational Studies, Muzaffarnagar, India

Dr. Baby Rabiya Parveen is a dedicated researcher currently pursuing a PhD in Pharmaceutical Chemistry from IFTM University, Moradabad. With a Master’s in Pharmaceutical Chemistry and a Bachelor’s in Pharmacy, both from S.D. College of Pharmacy, her academic journey has been marked by excellence and a commitment to advancing pharmaceutical sciences. Her research interests span the synthesis of novel pharmaceutical compounds and their biological evaluations, contributing significantly to her field. 🌟

Publication Profile

ORCID

Strengths for the Award:

  1. Extensive Educational Background: Rabiya Parveen is pursuing a PhD in Pharmaceutical Chemistry and holds both a Master’s and Bachelor’s degree in Pharmaceutical Chemistry with impressive academic performance.
  2. Diverse Workshop Participation: She has actively participated in numerous workshops and faculty development programs covering a wide range of topics relevant to pharmaceutical research, including intellectual property rights, drug regulatory affairs, and biotechnological applications.
  3. Research Contributions: Rabiya has contributed significantly to the field with multiple research papers on topics such as novel oxazine derivatives, antimicrobial agents, and drug synthesis. Her work on molecular docking and synthesis of new compounds demonstrates a strong commitment to advancing pharmaceutical science.
  4. Conference Presentations: She has presented her research at several national and international conferences, showcasing her work to a broader scientific audience and contributing to the dissemination of knowledge in the field.
  5. Industrial Experience: Her industrial training at Deepali Pharmaceuticals adds practical experience to her academic achievements, enhancing her understanding of real-world applications of her research.
  6. Book Chapters: Rabiya has contributed chapters to books on advanced topics like metallic nanoparticles and ghee standards, reflecting her expertise and ability to communicate complex concepts.

Areas for Improvement:

  1. Publication Record: While Rabiya has a commendable list of research papers, increasing the number of high-impact publications in top-tier journals could further strengthen her research profile.
  2. Research Impact: Demonstrating the practical impact of her research on pharmaceutical practice or policy could provide more evidence of her work’s significance.
  3. Collaborative Research: Engaging in collaborative projects with researchers from other institutions or industries might enhance the scope and applicability of her research.
  4. Grants and Funding: Securing research grants and funding could support more extensive studies and increase her visibility in the research community.

Education

Dr. Baby Rabiya Parveen is pursuing a PhD in Pharmaceutical Chemistry from IFTM University, Moradabad. She completed her Master of Pharmacy in Pharmaceutical Chemistry with honors from S.D. College of Pharmacy & Vocational Studies, Muzaffarnagar, and her Bachelor of Pharmacy from the same institution. Her academic background also includes a high distinction in both Intermediate and High School studies. 📚

Experience

Dr. Parveen has gained practical experience through a 45-day industrial training at Deepali Pharmaceuticals, Muzaffarnagar, where she applied her theoretical knowledge to real-world pharmaceutical practices. This hands-on experience complements her extensive academic training and research work. 🏭

Research Focus

Dr. Parveen’s research primarily focuses on the synthesis of novel pharmaceutical compounds and their pharmacological activities. Her work includes the development of new oxazine derivatives, Schiff bases, and isoxazole compounds, with a keen interest in their anti-inflammatory, antimicrobial, and anxiolytic activities. Her research contributes to the development of new therapeutic agents. 🔬

Awards and Honours

Dr. Parveen has been recognized for her academic and research achievements through various awards and honors. Her contributions to pharmaceutical sciences have been acknowledged in multiple conferences and workshops, reflecting her commitment to advancing the field. 🏆

Publications

“Synthesis of some new 3-[5-(substituted-phenyl)-[1,3,4]oxadiazole-2-yl]-1-napthalen-2-yl-propan-1-one” – Published in [Journal Name, Year].

“Synthesis and Biological Evaluation of Some New Amide Derivatives of Sulfonamide” – Published in [Journal Name, Year].

“Synthesis and biological evaluation of some new Schiff base 1,2,4-Triazole Derivatives” – Published in [Journal Name, Year].

“A Short Review on Sulfonamides with Antimicrobial Activity” – Published in [Journal Name, Year].

“A Short Review on Synthesis and Pharmacological Activity of Isoxazole” – Published in [Journal Name, Year].

Conclusion:

Baby Rabiya Parveen is a strong candidate for the Research for Best Researcher Award due to her solid educational background, active participation in professional development, significant research contributions, and industrial experience. Her diverse expertise and dedication to advancing pharmaceutical sciences are commendable. Addressing the areas for improvement, particularly in increasing high-impact publications and demonstrating the practical impact of her research, could further solidify her position as a leading researcher in her field.

 

Vuanghao Lim | Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Assoc Prof Dr. Vuanghao Lim | Pharmaceutical Science | Best Researcher Award

University Lecturer, USM, Malaysia

👨‍🔬 Lim Vuanghao is an Associate Professor at the Advanced Medical and Dental Institute, Universiti Sains Malaysia (USM). His extensive work in nanodrug delivery and green nano-synthesis has made him a recognized figure in the fields of pharmaceutical technology and metabolomics. He has held various leadership roles, including Head of the Integrative Medicine Cluster at USM. Lim’s research focuses on cutting-edge therapeutic strategies, emphasizing targeted drug delivery and the application of metabolomics in medical sciences.

Profile

Google Scholar

Strengths for the Award

Extensive Research Experience: Dr. Lim Vuanghao has a rich background in nanodrug delivery, green nano-synthesis, and metabolomics/chemometrics. His research contributions are well-documented across multiple platforms, including Web of Science, ORCID, Scopus, and Google Scholar.

Diverse Educational Background: Dr. Lim’s academic qualifications are impressive, with a Ph.D. in Pharmaceutical Technology, an M.Sc. in Pharmacy, a B.Sc. in Chemical Sciences, and additional qualifications in Acupuncture and Energy Medicine. This multidisciplinary education underpins his innovative research in nanotechnology and drug delivery systems.

Successful Grant Acquisition: Dr. Lim has secured significant research funding both internationally and nationally, demonstrating his capability to attract and manage research projects. These grants, such as those for breast cancer research and nanocomposite drug delivery systems, highlight his focus on high-impact research areas.

Graduate Supervision and Mentorship: He has successfully supervised several Ph.D. and Master’s students, which speaks to his role in developing the next generation of researchers. His supervision has led to the completion of innovative theses on topics such as green synthesis of nanoparticles and drug delivery systems.

Professional Recognition and Impact: Dr. Lim has been invited as a keynote speaker and research consultant on numerous occasions, indicating his expertise is well-recognized globally. His visiting fellowships and academic appointments in various countries further emphasize his international standing.

Professional and Community Service: His involvement in professional associations, such as the American Chemical Society and the Malaysian Institute of Chemistry, and his community service, particularly in environmental education and herbal medicine exploration, demonstrate a commitment to applying his expertise beyond academia.

Areas for Improvement

Publication Impact: While Dr. Lim’s research is broad and multidisciplinary, a focus on increasing the impact factor of his publications could strengthen his candidacy. Targeting top-tier journals and increasing citation metrics might further solidify his reputation as a leading researcher.

Research Diversity: Although Dr. Lim has a strong focus on nanotechnology and drug delivery, expanding his research into newer or emerging areas within pharmaceutical sciences could broaden his influence. Engaging in collaborative projects across different disciplines might also bring new perspectives and innovation.

Industry Collaboration: While Dr. Lim has some experience in consulting and contract research, increasing partnerships with the industry could enhance the practical application of his research. Establishing stronger ties with pharmaceutical companies or biotech firms could lead to commercialization opportunities.

Global Presence: Despite his international fellowships and visiting positions, further enhancing his global presence by leading international research consortia or hosting global conferences could elevate his profile further. Participation in global initiatives and publishing in international collaborations could be beneficial.

Education

🎓 Lim Vuanghao holds a PhD in Pharmaceutical Technology (2010) and an MSc in Pharmacy (2005) from Universiti Sains Malaysia. He also earned a B.Sc. (Hons) in Chemical Sciences from Universiti Putra Malaysia in 2002. Further enhancing his medical expertise, Lim completed a Doctor of Medicine in Acupuncture from the Indian Board of Alternative Medicines and a Diploma in Clinical Acupuncture and Energy Medicine from Xiamen University, China.

Experience

👨‍🏫 Lim Vuanghao has an extensive academic career, starting as a Research Assistant at the School of Pharmaceutical Sciences, USM, and later as a Lecturer at UCSI University. He has also served as the Head of the Integrative Medicine Cluster at USM, where he played a crucial role in advancing the institute’s research capabilities. Lim is also an active member of various grant evaluation panels and research committees.

Research Interest

🔬 Lim Vuanghao’s research interests revolve around nanodrug delivery systems, green nano-synthesis, and the application of metabolomics and chemometrics in medical research. His work aims to develop innovative therapeutic strategies, including targeted drug delivery systems for cancer treatment and the use of metabolomics to understand disease mechanisms better.

Awards

🏆 Lim Vuanghao has received numerous accolades, including an Academic Fellow Scheme (2023) at Universitas Airlangga, Indonesia, and a Senior Visiting Fellowship at Khesar Gyalpo University of Medical Sciences, Bhutan. His contributions to research have also been recognized through Visiting Professorships and Research Scholarships at various international institutions.

Publications Top Notes

📝 Selected Publications:

“Development of Quercetin PEGylated Nanodiamonds for Colon Cancer Inhibition” (2021, Universitas Airlangga). Link to Publication – Cited by 10 articles.

“Medicinal Herb of Clinacanthus Nutans for Nasopharyngeal Cancer: Biological Activity and Mechanism” (2021, Xinxiang Medical University). Link to Publication – Cited by 15 articles.

“Thiolated Alginate-PLGA Nanoparticles for Multi-Drug Resistant Breast Cancer” (2019, USM). Link to Publication – Cited by 20 articles.

Conclusion

Dr. Lim Vuanghao is a strong candidate for the “Best Researcher Award” due to his extensive research contributions, successful mentorship, and professional recognition. His work in nanodrug delivery and metabolomics is highly impactful, and his dedication to both academia and community service underscores his holistic approach to science. While there is room for growth in publication impact, research diversity, and industry collaboration, his current achievements position him as a leading figure in his field. His recognition as a global expert and his ability to secure substantial research funding further support his candidacy for this prestigious award.